Not finding it? Sign in to also search OpenAlex live.
-
Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials2020 Critical Reviews in Oncology/Hematology article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Ali Belkouz, Johanna W. Wilmink, Nadia Haj Mohammad, Jeroen Hagendoorn, Judith de Vos‐Geelen, C.H.C. Dejong, +6 more
18citations -
Evaluation of early C-reactive protein kinetics as an early response marker in biliary tract cancer patients treated with combined chemoimmunotherapy.2026 Journal of Clinical Oncology conference-abstract Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Gabriel Allo, Joshua Leutiger, Catherine Leyh, Christian Moehring, Ann-Kristin Zoeller, Vera Himmelsbach, +11 more
1citations -
Evaluation of early C‐reactive protein kinetics as an early response marker in biliary tract cancer treated with combined chemoimmunotherapy: A multicenter observational study
Gabriel Allo, Joshua Leutiger, Catherine Leyh, Christian Möhring, Ann‐Kristin Zöller, Vera Himmelsbach, +14 more
0citations -
Additional file 1 of Study protocol: a phase II study of trifluridine/tipiracil plus liposomal irinotecan as second-line therapy in advanced biliary tract cancer (TRITICC 2)
Linde Kehmann, Thorsten Götze, Maria Angeles Gonzalez-Carmona, Friedrich Foerster, Marie Berres, Raphael U. Mohr, +7 more
0citations -
Soluble urokinase plasminogen activator receptor (suPAR) predicts outcome after resection of biliary tract cancer2020 Zeitschrift für Gastroenterologie conference-paper Medicine Cholangiocarcinoma and Gallbladder Cancer Studies
Sven Heiko Loosen, Annemarie Breuer, Frank Tacke, Christian Trautwein, Thomas Longerich, Christoph Roderburg, +2 more
0citations -
Circulating levels of soluble urokinase plasminogen activator receptor (suPAR) to predict outcome after resection of biliary tract cancer.2020 Journal of Clinical Oncology conference-abstract Medicine Cholangiocarcinoma and Gallbladder Cancer Studies
Sven Heiko Loosen, Annemarie Breuer, Frank Tacke, Patrick H. Alizai, Tom Florian Ulmer, Christian Trautwein, +4 more
0citations -
Serum levels of CXCL13 are an independent predictor of survival following resection of biliary tract cancer2020 Zeitschrift für Gastroenterologie conference-paper Medicine Cholangiocarcinoma and Gallbladder Cancer Studies
SH Loosen, AA Roeth, PH Alizai, Jan Bednarsch, Mihael Vucur, TF Ulmer, +4 more
0citations -
Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer2022 Mediators of Inflammation article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Christoph Roderburg, Simon Labuhn, Jan Bednarsch, Sven Arke Lang, Anne T. Schneider, Linda Hammerich, +5 more
4citations -
Increased incidence, survival, and registration quality of primary hepato‐pancreato‐biliary cancers in the Netherlands Cancer Registry2025 International Journal of Cancer article Medicine Global Cancer Incidence and Screening Open access
Lydia G. van der Geest, Marianne van der Mark, Joanne Verheij, Arantza Fariña Sarasqueta, Judith de Vos‐Geelen, Marc G. Besselink, +7 more
4citations -
Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis2025 International Journal of Molecular Sciences review Medicine Peptidase Inhibition and Analysis Open access
Rutger B. Henrar, Floris A. Vuijk, George Louis Burchell, Susan van Dieren, Lioe‐Fee de Geus‐Oei, Geert Kazemier, +3 more
13citations -
Community-Acquired Escherichia coli Bacteremia after Age 50 and Subsequent Incidence of a Cancer Diagnosis: A Danish Population–Based Cohort Study2020 Cancer Epidemiology Biomarkers & Prevention article Medicine Urinary Tract Infections Management Open access
Kirstine K. Søgaard, Katalin Veres, Christina M. J. E. Vandenbroucke‐Grauls, Jan Paul Vandenbroucke, Henrik Toft Sørensen, Henrik Carl Schønheyder
5citations -
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)
Linde Kehmann, Marie‐Luise Berres, Maria Angeles Gonzalez-Carmona, Dominik Paul Modest, Raphael U. Mohr, Alexander Wree, +6 more
5citations -
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC): A phase III study utilizing the German Registry of Incidental Gallbladder Carcinoma Platform (GR)—The AIO/CALGP/ACO-GAIN-Trial.2020 Journal of Clinical Oncology conference-abstract Medicine Cholangiocarcinoma and Gallbladder Cancer Studies
Thorsten Oliver Goetze, Ulli Simone Bankstahl, Sven Arke Lang, Steffen Heeg, Wolf O. Bechstein, Andreas Anton Schnitzbauer, +9 more
0citations -
Perioperative chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone in gallbladder carcinoma or in front of radical resection in BTC: The phase III GAIN trial.2021 Journal of Clinical Oncology conference-abstract Medicine Cholangiocarcinoma and Gallbladder Cancer Studies
Thorsten Oliver Goetze, Sylvie Lorenzen, Ulli Simone Bankstahl, Sven Arke Lang, Uwe A. Wittel, Steffen Heeg, +14 more
3citations